Hexosaminidase A and Total

Message
This test is NOT useful for pregnant females or those treated with hormonal contraception.


Test Code
LAB01192


Alias/See Also
LAB01192
Mayo TC: NAGS
Mayo Test Name: Hexosaminidase A and Total Hexosaminidase, Serum
Sandhoff 
Tay Sachs


CPT Codes
83080 (x2)

Preferred Specimen
1.0 mL Serum
(Marble, Gold, Red)


Minimum Volume
0.5 mL Serum


Transport Temperature
Refrigerated


Specimen Stability
Refrigerated: 7 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross icterus


Methodology
Heat Inactivation, Fluorometric, Automated

Report Available
8-14 days


Limitations
GM2 activator deficiency (AB variant, GM2A) is a rare disorder with clinical features similar to Tay-Sachs and Sandhoff diseases; however, levels of both hexosaminidase A and B are normal. GM2 activator deficiency is not detected with this assay.


Reference Range
Hexosaminidase Total:
< or =15 years: > or = 20 nmol/min/mL
> or =16 years: 10.4-23.8 nmol/min/mL

Hexosaminidase Percent A
< or =15 years: 20-90%
> or =16 years: 56-80%

Interpretation is provided with report. 


Clinical Significance
Tay-Sachs and Sandhoff diseases, also referred to as GM2 gangliosidoses, are lysosomal storage disorders caused by deficiencies of the enzymes hexosaminidase A and hexosaminidase B, respectively. These isoenzymes are dimers that differ in their subunit composition. Hexosaminidase A is a heterodimer composed of 1 alpha and 1 beta subunit (alpha-beta), while hexosaminidase B is a homodimer composed of 2 beta subunits (beta-beta). The defective lysosomal degradation and the excessive accumulation of GM2 ganglioside and related glycolipids result in the development of the clinical symptomology observed in Tay-Sachs and Sandhoff diseases.
Tay-Sachs and Sandhoff diseases are autosomal recessive conditions. Tay-Sachs disease results from 2 varients in HEXA, which encodes for the alpha subunit of hexosaminidase and causes a deficiency of hexosaminidase A enzyme. An increased carrier frequency for Tay-Sachs disease is observed in individuals of Ashkenazi Jewish, Celtic, and French-Canadian ancestry. Patients with Sandhoff disease have 2 variants in HEXB, which encodes for the beta subunit of hexosaminidase and results in deficiencies in both hexosaminidase A and hexosaminidase B enzymes. Sandhoff disease does not exhibit an increased carrier frequency in any specific population. 


Performing Laboratory
Mayo Clinic Laboratories



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.